Stockholm, August 23, 2021 - Intervacc AB (“Intervacc”) announced today that the Norwegian Medicines Agency (NoMA) has granted a marketing authorisation for Strangvac® within Norway. Strangvac® is ... Read more
Stockholm, August 16, 2021 - Intervacc AB (“Intervacc”) announced today that the European Commission has granted a Marketing Authorisation for Strangvac® within the European Union. Strangvac® is a vaccine against equine ... Read more
Stockholm, July 2, 2021 - Intervacc AB (“Intervacc”) announced today that the Veterinary Medicines Directorate (VMD) of the United Kingdom has give a positive outcome on their application for a Marketing Authorisation ... Read more
Stockholm, June 17, 2021 - Intervacc AB (“Intervacc”) announced today that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency (EMA) has adopted a positive opinion, ... Read more